UBS ASSET MANAGEMENT AMERICAS INC - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 167 filers reported holding ANIKA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS INC ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$210,130,000
-9.6%
8,829
-15.2%
0.00%
Q2 2022$232,329,000
-51.9%
10,409
-45.9%
0.00%
Q1 2022$483,066,000
-29.9%
19,2380.0%0.00%
Q4 2021$689,297,000
-15.8%
19,2380.0%0.00%
Q3 2021$818,770,000
+18.3%
19,238
+20.4%
0.00%
Q2 2021$691,991,000
+2.5%
15,985
-3.4%
0.00%
Q1 2021$674,787,000
-9.9%
16,5430.0%0.00%
Q4 2020$748,736,000
+27.9%
16,5430.0%0.00%
Q3 2020$585,457,000
+75.8%
16,543
+87.4%
0.00%
Q2 2020$333,118,000
-27.0%
8,829
-44.1%
0.00%
Q1 2020$456,314,000
-46.6%
15,784
-4.1%
0.00%
-100.0%
Q4 2019$853,762,000
-1.8%
16,466
+4.0%
0.00%0.0%
Q3 2019$869,073,000
+222.5%
15,833
+138.6%
0.00%
Q2 2019$269,514,000
+16323.8%
6,635
+20006.1%
0.00%
Q1 2018$1,641,000
-7.8%
330.0%0.00%
Q4 2017$1,779,000
-7.1%
330.0%0.00%
Q3 2017$1,914,000
+17.6%
330.0%0.00%
Q2 2017$1,628,000
+519.0%
33
-99.4%
0.00%
Q3 2016$263,000
-10.8%
5,5000.0%0.00%
Q2 2016$295,000
+19.9%
5,5000.0%0.00%
Q1 2016$246,000
+17.1%
5,5000.0%0.00%
Q4 2015$210,000
-1.9%
5,500
+5.8%
0.00%
Q1 2015$214,000
-3.6%
5,200
+8.3%
0.00%
Q2 2014$222,0004,8000.00%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Euclidean Technologies Management, LLC 44,875$2,031,0002.14%
Parian Global Management LP 102,705$4,648,0001.16%
CAPITAL MANAGEMENT CORP /VA 93,035$4,211,0001.15%
Avidity Partners Management LP 731,000$33,085,0001.07%
Sio Capital Management, LLC 65,382$2,959,0000.61%
DIKER MANAGEMENT LLC 21,835$988,0000.50%
Archon Capital Management LLC 48,925$2,214,0000.38%
Caption Management, LLC 362,800$16,420,0000.37%
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 1,546,260$69,984,0000.20%
Boston Trust Walden Corp 378,167$17,116,0000.18%
View complete list of ANIKA THERAPEUTICS INC shareholders